A Single Center, Open Label, Stepwise, Dose Profiling Study to Evaluate the Efficacy and Safety of Four Dose Regimens of Inhaled TPI ASM8 in Patients With Allergic Asthma.
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2012
At a glance
- Drugs ASM 8 (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- 31 May 2012 Company added in the association field and additional lead trial centre identified as reported by ClinicalTrials.gov.
- 04 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Feb 2010 Actual patient number (14) added as reported by ClinicalTrials.gov.